Dr. Aaron Tejani, PharmD gave this presentation on October 5th, 2019 in Vancouver, BC at the "Bringing Best Evidence to Clinicians" medical education conference marking the 25th anniversary of the UBC Therapeutics Initiative. Dr. Tejani is a clinical assistant professor with the Faculty of Pharmaceutical Sciences (University of British Columbia), Medication use evaluation pharmacist with Lower … [Read more...]
[98] Does SPRINT change our approach to blood pressure targets?
Therapeutics Letter #821 summarized evidence from the Cochrane systematic review, Treatment blood pressure targets for hypertension.2 The Cochrane review was based on the 7 randomized controlled trials (RCTs) designed to test treatment targets that were available as of October 2008. The conclusion was that “Treating patients to lower than standard blood pressure (BP) targets (≤ 140-160/90-100 … [Read more...]